BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 19628432)

  • 1. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.
    Cani PD; Delzenne NM
    Curr Opin Pharmacol; 2009 Dec; 9(6):737-43. PubMed ID: 19628432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota in obesity and metabolic disorders.
    Sanz Y; Santacruz A; Gauffin P
    Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and the human microbiome.
    Ley RE
    Curr Opin Gastroenterol; 2010 Jan; 26(1):5-11. PubMed ID: 19901833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiome as therapeutic target.
    Cani PD; Delzenne NM
    Pharmacol Ther; 2011 May; 130(2):202-12. PubMed ID: 21295072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between obesity and the gut microbiota: relevance in nutrition.
    Delzenne NM; Cani PD
    Annu Rev Nutr; 2011 Aug; 31():15-31. PubMed ID: 21568707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, metabolic syndrome, and microbiota: multiple interactions.
    Tilg H
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S16-8. PubMed ID: 20535027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders.
    Musso G; Gambino R; Cassader M
    Curr Opin Lipidol; 2010 Feb; 21(1):76-83. PubMed ID: 19915460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.
    Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R
    Diabetes; 2008 Jun; 57(6):1470-81. PubMed ID: 18305141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders.
    Neyrinck AM; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):722-8. PubMed ID: 20823777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.
    Cani PD; Delzenne NM; Amar J; Burcelin R
    Pathol Biol (Paris); 2008 Jul; 56(5):305-9. PubMed ID: 18178333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.
    Molinaro F; Paschetta E; Cassader M; Gambino R; Musso G
    Gastroenterol Clin North Am; 2012 Dec; 41(4):843-54. PubMed ID: 23101690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microflora as a target for energy and metabolic homeostasis.
    Cani PD; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):729-34. PubMed ID: 18089955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the gut microbiota on obesity and glucose homeostasis.
    Greiner T; Bäckhed F
    Trends Endocrinol Metab; 2011 Apr; 22(4):117-23. PubMed ID: 21353592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the development of the intestinal microbiota in infancy.
    Vael C; Desager K
    Curr Opin Pediatr; 2009 Dec; 21(6):794-800. PubMed ID: 19770768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.